Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arjo AB ( ($SE:ARJO.B) ) just unveiled an update.
Arjo AB reported a 3.8% organic sales growth in Q3 2025, despite a slight decline in net sales. The company maintained profitability with an adjusted operating profit increase of over 20%, excluding currency and tariff effects. Arjo’s strategic focus on cost efficiency and market expansion, particularly in India, contributed to its performance. The appointment of Andréas Elgaard as the new CEO and an upgraded ESG rating to AAA by MSCI highlight Arjo’s commitment to sustainability and leadership transition.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo AB operates in the healthcare industry, providing medical devices and solutions focused on improving patient mobility and care. The company is known for its patient handling equipment, medical beds, and solutions that enhance healthcare efficiency and safety. Arjo has a strong market presence in North America, Europe, and emerging markets like India.
Average Trading Volume: 418,260
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK8.47B
For a thorough assessment of ARJO.B stock, go to TipRanks’ Stock Analysis page.